Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. RNA targeting with CRISPR–Cas13

RNA targeting with CRISPR–Cas13

Thumbnail Image
Download
Name

nihms920681.pdf

Size

2.48 MB

Format

Adobe PDF

Checksum (MD5)

44cea0cccfb8407f36e7593ce4b455cb

Download all files submitted through automated deposit
sword-2018-06-28.original.zip (2.03 MB)
Author(s)
Essletzbichler, Patrick
•
Belanto, Joseph J.
•
Verdine, Vanessa
•
Kellner, Max J.
•
Voytas, Daniel F.
•
Gootenberg, Jonathan S
•
Han, Shuo
•
Joung, Julia
•
Cox, David Benjamin Turitz
•
Regev, Aviv
more
Date Issued
October 2017
Journal
Nature
Publisher
Nature Publishing Group
Citation
Abudayyeh, Omar O. et al. “RNA Targeting with CRISPR–Cas13.” Nature 550, 7675 (October 2017): 280–284 © 2017 Macmillan Publishers Limited, part of Springer Nature
Version
Author's final manuscript
Abstract
RNA has important and diverse roles in biology, but molecular tools to manipulate and measure it are limited. For example, RNA interference1-3 can efficiently knockdown RNAs, but it is prone to off-target effects4, and visualizing RNAs typically relies on the introduction of exogenous tags5. Here we demonstrate that the class 2 type VI6,7 RNA-guided RNA-targeting CRISPR-Cas effector Cas13a8(previously known as C2c2) can be engineered for mammalian cell RNA knockdown and binding. After initial screening of 15 orthologues, we identified Cas13a from Leptotrichia wadei (LwaCas13a) as the most effective in an interference assay in Escherichia coli. LwaCas13a can be heterologously expressed in mammalian and plant cells for targeted knockdown of either reporter or endogenous transcripts with comparable levels of knockdown as RNA interference and improved specificity. Catalytically inactive LwaCas13a maintains targeted RNA binding activity, which we leveraged for programmable tracking of transcripts in live cells. Our results establish CRISPR-Cas13a as a flexible platform for studying RNA in mammalian cells and therapeutic development.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Biology
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Massachusetts Institute of Technology. Department of Chemistry
McGovern Institute for Brain Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/116680
DOI of Published Version
https://doi.org/10.1038/NATURE24049
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.